Page last updated: 2024-08-16
triclosan and amg531
triclosan has been researched along with amg531 in 2 studies
Research
Studies (2)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
Authors
| Authors | Studies |
|---|---|
| Chen, J; Gao, K; Huang, F; Tepe, JJ; Wang, R; Wei, GW | 1 |
| Cai, JP; Cao, J; Chan, CC; Chan, JF; Chik, KK; Choi, GK; Chu, H; Huang, J; Jin, DY; Liang, M; Tsang, TG; Wen, L; Ye, ZW; Yin, F; Yuan, S; Yuen, KY | 1 |
Other Studies
2 other study(ies) available for triclosan and amg531
| Article | Year |
|---|---|
Perspectives on SARS-CoV-2 Main Protease Inhibitors.
Topics: Antiviral Agents; Coronavirus 3C Proteases; Humans; Protease Inhibitors | 2021 |
Screening of an FDA-Approved Drug Library with a Two-Tier System Identifies an Entry Inhibitor of Severe Fever with Thrombocytopenia Syndrome Virus.
Topics: Antiviral Agents; Benzoates; Bunyaviridae Infections; Drug Approval; Drug Discovery; Drug Repositioning; Hydrazines; Inhibitory Concentration 50; Molecular Docking Simulation; Phlebovirus; Pyrazoles; Small Molecule Libraries; Triclosan; United States; United States Food and Drug Administration; Virus Internalization | 2019 |